We deliver strong returns for investors, by driving long-term growth through our bold vision, dynamic business model and innovative pipeline.
Events and presentations
Loading events...
Key financial data
€267M
Revenue for 2024
Quick links
Financial reports
Loading reports...
IR contact
Cosmo Pharmaceuticals NV
Riverside 2
49 Sir John Rogerson's Quay
Grand Canal Dock
Dublin, D02 KV60
Ireland
